Mylan NV’s planned merger with Pfizer’s Upjohn gets greenlight after drug sell-off
The competition watchdog will not oppose Mylan NV’s proposed merger with Pfizer’s Upjohn Inc after the global pharmaceutical giants agreed to sell several off-patent brands to dispel competition concerns.